A detailed history of Atom Investors LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Atom Investors LP holds 259,824 shares of KPTI stock, worth $174,082. This represents 0.02% of its overall portfolio holdings.

Number of Shares
259,824
Previous 261,847 0.77%
Holding current value
$174,082
Previous $227,000 5.29%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.06 $1,416 - $2,144
-2,023 Reduced 0.77%
259,824 $215,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $15,181 - $27,571
17,450 Added 7.14%
261,847 $227,000
Q1 2024

May 15, 2024

BUY
$0.72 - $1.66 $19,949 - $45,993
27,707 Added 12.79%
244,397 $369,000
Q4 2023

Feb 14, 2024

BUY
$0.68 - $1.31 $17,588 - $33,883
25,865 Added 13.55%
216,690 $186,000
Q3 2023

Nov 14, 2023

BUY
$1.14 - $1.81 $7,074 - $11,232
6,206 Added 3.36%
190,825 $255,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $330,468 - $847,401
184,619 New
184,619 $330,000
Q3 2020

Nov 13, 2020

SELL
$14.14 - $19.71 $5.51 Million - $7.68 Million
-389,807 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$16.6 - $25.25 $1.37 Million - $2.08 Million
-82,375 Reduced 17.45%
389,807 $7.38 Million
Q1 2020

May 15, 2020

BUY
$14.38 - $27.72 $2.07 Million - $3.99 Million
144,064 Added 43.91%
472,182 $9.07 Million
Q4 2019

Feb 13, 2020

SELL
$9.23 - $19.67 $715,315 - $1.52 Million
-77,499 Reduced 19.11%
328,118 $6.29 Million
Q3 2019

Nov 14, 2019

SELL
$5.66 - $11.85 $83,513 - $174,846
-14,755 Reduced 3.51%
405,617 $3.9 Million
Q2 2019

Aug 14, 2019

BUY
$4.32 - $6.43 $1.82 Million - $2.7 Million
420,372 New
420,372 $2.52 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $53.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.